RA Capital Nexus Fund, L.P. Plans to Sell Common Stock of Vor Biopharma Inc.

RA Capital Nexus Fund, L.P., a director and 10% stockholder of Vor Biopharma Inc., has filed a Form 144 indicating its intention to sell 8,430 shares of common stock. The shares were acquired on February 12, 2019, through a private financing transaction. The approximate sale date is set for October 15, 2025, with an aggregate market value of $254,754.60. The sale will be executed through BTIG, LLC. There are no securities sold in the past three months to report.